Next Article in Journal
The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration
Previous Article in Journal
Peptide Vaccines for Hypertension and Diabetes Mellitus
Article

CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance

1
Cancer Biology Research Center, Sanford Research, Sioux Falls, SD 57104, USA
2
Sanford Health, 2301 East 60th Street North, Sioux Falls, SD 57104, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Vaccines 2014, 2(4), 841-853; https://doi.org/10.3390/vaccines2040841
Received: 24 October 2014 / Revised: 12 November 2014 / Accepted: 21 November 2014 / Published: 10 December 2014
Standard-of-care cisplatin and radiation therapy (CRT) provides significant tumor control of human papillomavirus (HPV)-mediated head and neck squamous cell carcinomas (HNSCCs); this effectiveness depends on CRT-mediated activation of the patient’s own immune system. However, despite good survival, patients suffer significant morbidity necessitating on-going studies to define novel therapies that alleviate this burden. Given the role of the immune system in tumor clearance, immune modulation may further potentiate the CRT-activated response while potentially decreasing morbidity. CD137, an inducible cell surface receptor found on activated T cells, is involved in differentiation and survival signaling in T cells upon binding of its natural partner (CD137L). A number of studies have shown the effectiveness of targeting this immune-stimulatory pathway in regards to tumor clearance. Here, we test its role in HPV+ HNSCC tumor clearance using a previously characterized mouse model. We show that amplification of this stimulatory pathway synergizes with CRT for enhanced tumor clearance. Interestingly, tumor clearance is further potentiated by local tumor cell expression of CD137L. View Full-Text
Keywords: CD137; immune; HPV; mouse; squamous CD137; immune; HPV; mouse; squamous
Show Figures

Figure 1

MDPI and ACS Style

Lucido, C.T.; Vermeer, P.D.; Wieking, B.G.; Vermeer, D.W.; Lee, J.H. CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance. Vaccines 2014, 2, 841-853. https://doi.org/10.3390/vaccines2040841

AMA Style

Lucido CT, Vermeer PD, Wieking BG, Vermeer DW, Lee JH. CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance. Vaccines. 2014; 2(4):841-853. https://doi.org/10.3390/vaccines2040841

Chicago/Turabian Style

Lucido, Christopher T.; Vermeer, Paola D.; Wieking, Bryant G.; Vermeer, Daniel W.; Lee, John H. 2014. "CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance" Vaccines 2, no. 4: 841-853. https://doi.org/10.3390/vaccines2040841

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop